MPX Bioceutical Corporation (CSE: MPX) (OTCQX: MPXEF) - Investor Dashboard

MPX Bioceutical Corp
CSE Symbol: MPX
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: 83
Established: 1974
CEO: Scott Boyes

MPX Bioceutical Corporation – Management & Advisory Team

Scott Boyes – President & CEO

W. Scott Boyes is the President, Chief Executive Officer and a director of the Corporation and devotes 100% of his time towards the business of the Corporation as an employee of the Corporation. His responsibilities include leadership of the Corporation, including, but not limited to, the general management, strategy and expansion of the BCC Corporate Group. Mr. Boyes sits on the Corporation’s Audit Committee and Corporate Governance and Nominating Committee.

Mr. Boyes is a seasoned senior executive with diversified and cross-functional experience, combining MBA credentials with a strong career background in revenue development and general management. Prior to the CGX Acquisition, Mr. Boyes was President of CGX where he focused on general management of CGX. Since August, 2008, Mr. Boyes has been President of NCD Associates, where he focused his consulting services on financial restructuring, and revenue enhancement and streamlining business processes for distressed or high growth companies. In 2005, Mr. Boyes founded and developed Railcrew Xpress Corporation, a specialized passenger transportation company servicing U.S. railroads, and served as its President until 2008. There, he developed and led the sales and customer service teams, managed the acquisition and integration of three competitor companies and developed and deployed sophisticated dispatch, tracking and reporting technology. From 2000 to 2005, Mr. Boyes served as President and Chief Executive Officer of Hallcon Corporation where he was responsible for the senior executive management of the company and its operating subsidiaries. Previously, he served as a Vice President a large Canadian Bank and Vice President and General manager of a business unit within a multinational commercial finance company always with a focus on marketing and revenue development.

Beth Stavola – COO

Elizabeth M. Stavola is the COO of MPX. Ms. Stavola the founder of Stavola Medical Marijuana Holdings, Health for Life Inc., GreenMart of Nevada, GreenMart of Maryland, Elemental Health Group of Pennsylvania, and CBD For Life. She has been the driving force behind the development of these thriving cannabis businesses into profitable, strong brands. Prior to her successful career in the cannabis industry, Ms. Stavola was a senior Wall Street executive, where she spent most of her career at Jefferies and Company, most recently as Senior Vice President, Institutional Equity Sales. In 1992, Ms. Stavola received a Bachelor of Science in Finance and Economics from Monmouth University.

David McLaren – CFO

David McLaren is the CFO of the Corporation. He has more than 25 years of financial experience, including a decade of experience at the CFO level. Before joining MPX, he was the CFO of Ontario Drive & Gear Limited. He has also served as CFO of Belmont Meats Limited, Redpath Sugar Limited, and Nealanders International, Inc. Mr. McLaren earned a Bachelor’s degree in commerce from McMaster University. He is also a Chartered Professional Accountant.

Michael Arnkvarn– VP of Marketing and Product Development

Michael Arnkvarn is the Vice President of Marketing and Product Development for MPX. He has a background in the operation of small to medium businesses. He completed a Bachelor of Science in Agricultural Sciences at McGill University.

Significant Insider Ownership

CEO Scott Boyes
3.9mm shares, 3.5mm options at $0.20

COO Beth Stavola
8 million shares and 3.5 million options at $1.00

Hi-Med LLC
25.73mm shares

Visit MPX Bioceutical Corporation,

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. MPX Bioceutical Corporation is a client of NCV Media, LLC. Read our full disclaimer.